0001776111-22-000001.txt : 20221118 0001776111-22-000001.hdr.sgml : 20221118 20221118163035 ACCESSION NUMBER: 0001776111-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221118 DATE AS OF CHANGE: 20221118 EFFECTIVENESS DATE: 20221118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MBX Biosciences, Inc. CENTRAL INDEX KEY: 0001776111 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-465364 FILM NUMBER: 221402325 BUSINESS ADDRESS: STREET 1: 12406 HORESHAM STREET CITY: CARMEL STATE: IN ZIP: 46032 BUSINESS PHONE: 3179893100 MAIL ADDRESS: STREET 1: 12406 HORESHAM STREET CITY: CARMEL STATE: IN ZIP: 46032 D 1 primary_doc.xml X0708 D LIVE 0001776111 MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 CARMEL IN INDIANA 46032 317-659-0200 DELAWARE None None Corporation true 2019 Peter Kent Hawryluk c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Executive Officer Director Richard DiMarchi c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Executive Officer Director Ora Pescovitz c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Director James M. Cornelius c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Director Carl Gordon c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Director Patrick Heron c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Director Edward Mathers c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Director Tiba Aynechi c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Director Richard Bartram c/o MBX Biosciences, Inc. 11711 N. Meridian Street, Suite 300 Carmel IN INDIANA 46032 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-11-07 true true false 0 115184430 46675441 68508989 Amount sold includes $10,184,444 from conversion of promissory notes false 20 0 0 0 false MBX Biosciences, Inc. /s/Peter Kent Hawryluk Peter Kent Hawryluk President & CEO 2022-11-18